Skip to main content
Fig. 6 | Clinical Proteomics

Fig. 6

From: Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)

Fig. 6

The relative PTMA expression was tested by QDB in ESCC and adjacent normal tissues from 64 esophageal cancer patients. a The differential expression of PTMA was shown in each pair of tissues. b The PTMA expression was up-regulated in esophageal cancer tissues from the average of 64 pairs of tissues

Back to article page